Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells

Dong-Yun Lee1, Cheong-Rae Roh, Young-Hee Kang

  • 1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Maturitas
|July 6, 2013
PubMed

Insights

Black cohosh extract increases plasminogen activator inhibitor type 1 (PAI-1) in vascular cells, potentially impairing blood clot breakdown. This suggests a negative cardiovascular effect on fibrinolysis.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Molecular Biology

Background:

  • Black cohosh (Cimicifuga racemosa) is used for menopausal symptoms.
  • Cardiovascular effects of black cohosh are not well-studied.
  • The plasminogen activator system regulates blood clot breakdown (fibrinolysis).

Purpose of the Study:

  • To investigate the effect of black cohosh extract on the plasminogen activator system.
  • To examine the impact on vascular smooth muscle cells (VSMCs).

Main Methods:

  • VSMCs were isolated from rat aortae.
  • Black cohosh extract (BcEx) was applied to cultured VSMCs.
  • Protein expression and activity of PAI-1 and t-PA were measured using Western blot, ELISA, and zymography.

Main Results:

  • BcEx significantly increased PAI-1 protein expression and activity.
  • BcEx did not affect t-PA protein expression but decreased free t-PA activity.
  • The effect on PAI-1 was inhibited by Vitamin E, suggesting an oxidant mechanism, and not affected by an estrogen receptor antagonist.

Conclusions:

  • Black cohosh extract stimulates PAI-1 expression and activity in VSMCs, likely through an oxidant pathway.
  • This action reduces free t-PA, potentially inhibiting fibrinolysis.
  • Findings suggest black cohosh may negatively impact cardiovascular health by affecting blood clot breakdown.
Abstract

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...